Robert J. Terifay, SVP Commercial at REGENERON PHARMACEUTICALS INC (REGN), sold 24,375 shares at $448.01 ($10.9M) on 2015-03-17, disclosed to the SEC on 2015-03-18.
Scheduled sale ($10.9M) by SVP Commercial under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $444.46 | 11,703 | $5.2M | 47.7% |
| 2 | $444.46 | 1,679 | $746K | 6.8% |
| 3 | $448.01 | 2,600 | $1.2M | 10.7% |
| 4 | $448.87 | 300 | $135K | 1.2% |
| 5 | $450.18 | 2,093 | $942K | 8.6% |
| 6 | $450.95 | 700 |
| $316K |
| 2.9% |
| 7 | $452.61 | 3,200 | $1.4M | 13.3% |
| 8 | $453.28 | 1,700 | $771K | 7.1% |
| 9 | $454.00 | 400 | $182K | 1.7% |
| Total | $447.41 avg | 24,375 | $10.9M | 100% |
| Filing → |
| REGN | SELL | 2015-02-25 | $4.7M | — | Filing → |
| REGN | SELL | 2014-11-19 | $9.1M | — | Filing → |
| REGN | SELL | 2014-02-19 | $4.3M | — | Filing → |